Figure 1A demonstrates enhanced TG2 mRNA expressions in 6 randomly selected SFMCs from 16 patients with GA, as compared to that of healthy donors or rheumatoid arthritis patients. This evidence concerns the gene TGM2 and rheumatoid arthritis.